Cancer Stratification by Molecular Imaging
The lack of specificity of traditional cytotoxic drugs has triggered the development of anticancer agents that selectively address specific molecular targets. An intrinsic property of these specialized drugs is their limited applicability for specific patient subgroups. Consequently, the generation...
Main Authors: | Justus Weber, Uwe Haberkorn, Walter Mier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/3/4918 |
Similar Items
-
Tumor Hypoxia Imaging Agents in Nuclear Medicine
by: Mahtab Mohammadpour, et al.
Published: (2017-01-01) -
Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives
by: Artor Niccoli Asabella, et al.
Published: (2017-08-01) -
Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs)
by: Loganathan Rangasamy, et al.
Published: (2019-08-01) -
A Bayesian Approach To Positron Emission Tomography
by: Mondal, Partha Pratim
Published: (2011) -
Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
by: Jonatan Dewulf, et al.
Published: (2020-07-01)